• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义效能:国际勃起功能指数简版与扩展前列腺癌指数综合量表的比较

Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.

作者信息

Schroeck Florian R, Donatucci Craig F, Smathers Emily C, Sun Leon, Albala David M, Polascik Thomas J, Moul Judd W, Krupski Tracey L

机构信息

Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Cancer. 2008 Nov 15;113(10):2687-94. doi: 10.1002/cncr.23887.

DOI:10.1002/cncr.23887
PMID:18816628
Abstract

BACKGROUND

Both the 5-item short version of the International Index of Erectile Function (IIEF-5) and the Expanded Prostate Cancer Index Composite (EPIC) have been used to assess erectile function. In this study, the authors compared various definitions of potency according to the IIEF-5 and the EPIC.

METHODS

Patients with prostate cancer who had completed the IIEF-5 and the EPIC within 7 days of each other were included. The Spearman correlation coefficient (rho) was calculated to assess the relation between IIEF-5 and EPIC sexual domain scores. Concordance of potency rates by IIEF-5 and EPIC was assessed in cross-tabulations. By calculating the area under the receiver operator characteristics (ROC) curve (AUC), the authors ascertained the discriminative ability of the IIEF-5 score to identify potent men as defined by the EPIC.

RESULTS

Analyzing 102 questionnaire pairs, IIEF-5 and EPIC domain scores were found to be highly correlated (rho = 0.776). EPIC sexual domain scores > or =60 had high concordance with IIEF-5 scores > or =17 (98%) and with nearly all single-item definitions of potency (> or =71%). However, an EPIC sexual domain score > or =80 was a very strict definition of potency, and only 54% of patients with IIEF-5 scores > or =22 met this threshold. On the basis of ROC analysis (AUC = 0.90), an IIEF-5 score > or =20 was identified as the ideal cutoff for defining potency and corresponded with an EPIC sexual domain score > or =60.

CONCLUSIONS

IIEF-5 and EPIC scores were highly correlated, but potency rates varied widely, depending on the definition of potency. The current results help with the interpretation of sexual function outcomes data in patients with prostate cancer.

摘要

背景

国际勃起功能指数5项简短版(IIEF-5)和扩展前列腺癌指数综合量表(EPIC)均已用于评估勃起功能。在本研究中,作者根据IIEF-5和EPIC比较了不同的性功能定义。

方法

纳入在7天内先后完成IIEF-5和EPIC的前列腺癌患者。计算Spearman相关系数(rho)以评估IIEF-5与EPIC性领域得分之间的关系。通过交叉表评估IIEF-5和EPIC性功能正常率的一致性。通过计算受试者操作特征(ROC)曲线下面积(AUC),作者确定IIEF-5评分识别EPIC定义的性功能正常男性的鉴别能力。

结果

分析102对问卷,发现IIEF-5与EPIC领域得分高度相关(rho = 0.776)。EPIC性领域得分≥60与IIEF-5得分≥17高度一致(98%),与几乎所有单项性功能正常定义也高度一致(≥71%)。然而,EPIC性领域得分≥80是一个非常严格的性功能正常定义,只有54%的IIEF-5得分≥22的患者达到该阈值。基于ROC分析(AUC = 0.90),IIEF-5得分≥20被确定为定义性功能正常的理想临界值,对应于EPIC性领域得分≥60。

结论

IIEF-5和EPIC得分高度相关,但性功能正常率因性功能正常的定义不同而有很大差异。目前的结果有助于解释前列腺癌患者的性功能结果数据。

相似文献

1
Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.定义效能:国际勃起功能指数简版与扩展前列腺癌指数综合量表的比较
Cancer. 2008 Nov 15;113(10):2687-94. doi: 10.1002/cncr.23887.
2
Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?国际勃起功能指数勃起功能领域评分与夜间阴茎胀大及硬度测量结果的比较:二者能否相互预测?
BJU Int. 2006 Jul;98(1):105-9; discussion 109. doi: 10.1111/j.1464-410X.2006.06246.x.
3
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.局限性前列腺癌男性患者记忆性国际勃起功能指数领域评分的可靠性
Urology. 2005 Jan;65(1):131-5. doi: 10.1016/j.urology.2004.08.054.
4
Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.前列腺癌指数复合量表与尿失禁症状指数和男性健康问卷用于评估前列腺切除术后的功能结局。
J Urol. 2009 Jul;182(1):221-7; discussion 227-8. doi: 10.1016/j.juro.2009.02.155. Epub 2009 May 17.
5
Reconsidering the use of the International Index of Erectile Function questionnaire in evaluating the preoperative erectile function status of patients undergoing radical prostatectomy.重新审视国际勃起功能指数问卷在评估前列腺癌根治术患者术前勃起功能状态中的应用。
BJU Int. 2007 Aug;100(2):368-70. doi: 10.1111/j.1464-410X.2007.06898.x.
6
Clinical interpretation of the Expanded Prostate Cancer Index Composite-Short Form sexual summary score.扩展前列腺癌指数综合简表性总结评分的临床解读
J Urol. 2009 Dec;182(6):2844-9. doi: 10.1016/j.juro.2009.08.088. Epub 2009 Oct 17.
7
Erectile function durability following permanent prostate brachytherapy.永久性前列腺近距离放射治疗后的勃起功能持久性
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):639-48. doi: 10.1016/j.ijrobp.2008.11.058. Epub 2009 Mar 21.
8
Comparison of validated instruments measuring sexual function in men.比较男性性功能的有效测量工具。
Urology. 2010 Aug;76(2):380-6. doi: 10.1016/j.urology.2010.04.033. Epub 2010 Jun 22.
9
Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.勃起硬度:定义勃起功能障碍治疗反应的一个统一因素。
Urology. 2006 Sep;68(3 Suppl):17-25. doi: 10.1016/j.urology.2006.05.041.
10
Erectile function after brachytherapy with external beam radiation for prostate cancer.前列腺癌近距离放疗联合外照射后的勃起功能
Arch Androl. 2004 Jul-Aug;50(4):295-301. doi: 10.1080/01485010490448444.

引用本文的文献

1
Association Among Lower Urinary Tract Symptoms, Erectile Function, and Sexual Satisfaction: Results from the Brazil LUTS Study.下尿路症状、勃起功能和性满意度之间的关联:巴西下尿路症状研究结果
Sex Med. 2020 Mar;8(1):45-56. doi: 10.1016/j.esxm.2019.09.003. Epub 2019 Dec 4.
2
Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?EPIC 领域评分解读——领域评分如何转化为功能结局?
J Urol. 2019 Dec;202(6):1150-1158. doi: 10.1097/JU.0000000000000392. Epub 2019 Jun 19.
3
Sexual quality of life for localized prostate cancer: a cross-cultural study between Japanese and American men.
局限性前列腺癌患者的性生活质量:一项日本男性与美国男性之间的跨文化研究。
Reprod Med Biol. 2011 Feb 16;10(2):59-68. doi: 10.1007/s12522-011-0076-7. eCollection 2011 Jun.
4
Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.解读多个经过验证的工具的患者报告的尿控和性功能结果。
J Urol. 2017 Sep;198(3):671-677. doi: 10.1016/j.juro.2017.03.121. Epub 2017 Mar 22.
5
Translation and validation of tools for assessing health-related quality of life and male sexual function in Hong Kong Chinese patients during transitional cancer survivorship.香港华裔癌症幸存者过渡期间健康相关生活质量及男性性功能评估工具的翻译与验证
Support Care Cancer. 2017 Jul;25(7):2187-2193. doi: 10.1007/s00520-017-3624-9. Epub 2017 Feb 17.
6
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.前列腺癌临床局限性治疗的ProtecT随机试验中的患者报告结局:研究设计、基线泌尿、肠道及性功能和生活质量
BJU Int. 2016 Dec;118(6):869-879. doi: 10.1111/bju.13582. Epub 2016 Aug 17.
7
Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial.探索前列腺癌手术后基于夫妻的性心理支持的可行性和可接受性:一项试点随机对照试验的研究方案
Trials. 2014 May 24;15:183. doi: 10.1186/1745-6215-15-183.
8
Potency preservation following stereotactic body radiation therapy for prostate cancer.立体定向体部放射治疗前列腺癌后的疗效保存。
Radiat Oncol. 2013 Nov 1;8:256. doi: 10.1186/1748-717X-8-256.
9
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.使用 EPIC 测量和预测前列腺癌相关生活质量变化用于临床实践。
J Urol. 2014 Mar;191(3):638-45. doi: 10.1016/j.juro.2013.09.040. Epub 2013 Sep 25.
10
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.60 岁及以下男性前列腺癌质子治疗后的勃起功能、尿失禁和其他生活质量结果。
Cancer. 2012 Sep 15;118(18):4619-26. doi: 10.1002/cncr.27398. Epub 2012 Jan 17.